<DOC>
<DOCNO>
EP-0002482
</DOCNO>
<TEXT>
<DATE>
19790627
</DATE>
<IPC-CLASSIFICATIONS>
C07D-279/02 A61K-31/427 C07D-513/00 C07D-275/06 C07D-279/00 C07D-417/00 C07D-275/00 C07D-417/12 C07C-91/12 C07D-513/14 A61K-31/5415 <main>C07D-417/12</main> A61K-31/54 A61P-29/00 
</IPC-CLASSIFICATIONS>
<TITLE>
4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxides, processes for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
thomae gmbh dr kde<sep>dr. karl thomae gmbh<sep>dr. karl thomae gmbh birkendorferstrasse 65d-88397 biberachde <sep>dr. karl thomae gmbh<sep>
</APPLICANT>
<INVENTOR>
engel wolfhard dr dipl-chem<sep>engelhardt gunther dr<sep>seeger ernst dr dipl-chem<sep>trummlitz gunter dr dipl-chem<sep>engel, wolfhard, dr. dipl.-chem.<sep>engelhardt, gunther, dr.<sep>seeger, ernst, dr. dipl.-chem.<sep>trummlitz, gunter, dr. dipl.-chem.<sep>engel, wolfhard, dr. dipl.-chem.mozartstrasse 13d-7950 biberach 1de<sep>engelhardt, günther, dr.unterer bühl 18d-7950 biberach 1de<sep>seeger, ernst, dr. dipl.-chem.alpenstrasse 39d-7950 biberach 1de<sep>trummlitz, günter, dr. dipl.-chem.mozartstrasse 4d-7950 biberach 1de<sep>engel, wolfhard, dr. dipl.-chem.  <sep>engelhardt, gunther, dr. <sep>seeger, ernst, dr. dipl.-chem.<sep>trummlitz, gunter, dr. dipl.-chem.<sep>engel, wolfhard, dr. dipl.-chem.mozartstrasse 13d-7950 biberach 1de<sep>engelhardt, günther, dr.unterer bühl 18d-7950 biberach 1de<sep>seeger, ernst, dr. dipl.-chem.alpenstrasse 39d-7950 biberach 1de<sep>trummlitz, günter, dr. dipl.-chem.mozartstrasse 4d-7950 biberach 1de<sep>
</INVENTOR>
<ABSTRACT>
New 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides of the general formula I, in which R₁ is a hydrogen atom or a methyl or ethyl group, R₂ a methyl, ethyl or n-propyl groupand y are a hydrogen atom, the methyl or methoxy group or a fluorine or chlorine atom and their physiologically acceptable salts with inorganic or organic bases with anti-inflammatory and inflammatory pain of the effect of the treatment of, for example, rheumatic diseases, with these compounds by good compatibility andcharacterized by a large therapeutic width.The compounds are prepared by methods known per se, for example by reacting a 4-hydroxy-2H-1,2-benzothiazine 1,1-dioxide 3-carboxylic acid derivative with a 2-aminothiazole substituted in the 5-position or by alkylation of thePosition 2 of a 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide.
</ABSTRACT>
</TEXT>
</DOC>
